13,14-dihydro-15-keto-tetranor Prostaglandin D2 – 10 µg

Brand:
Cayman
CAS:
1204116-69-7
Storage:
-20
UN-No:
De Minimis - 1170 / 3

A common metabolic pathway for several prostaglandins (PGs), including PGD2, involves the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω-carbon produces the abundant urinary metabolites, including tetranor-PGDM.{15162} 13,14-dihydro-15-keto-tetranor PGD2 is a potential metabolite of PGD2. It would be produced from the known metabolite 13,14-dihydro-15-keto PGD2 (Item No. 12610), which is a known agonist for the CRTH2/DP2 receptor.{5248}  

 

SKU: - Category:

Description

A potential metabolite of PGD2, presumably produced from the known metabolite 13,14-dihydro-15-keto PGD2


Formal name: 9α-hydroxy-11,15-dioxo-2,3,4,5-tetranor-prostanoic acid

Synonyms: 

Molecular weight: 298.4

CAS: 1204116-69-7

Purity: ≥95%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway